Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

An interview with Professor Monaco on being an Oxford-Harrington Scholar and how her research will change cardiovascular healthcare.

Oxford-Harrington Scholar Professor Claudia Monaco talked to OxfordMedSci News on the benefits of the Oxford-Harrington Scholarship Programme and how the Harrington Discovery Institute’s drug development experts are helping her think translationally about her research in order to move her cardiovascular inflammation research from the lab to the clinic.

Her lab at the Kennedy Institute studies inflammation in metabolic diseases such as atherosclerosis by looking at immune cells in blood vessel walls. Atherosclerosis is one of the main causes of cardiovascular disease and a major cause of death worldwide. 

You can read the full interview here.

Similar stories

Connects-UK launches to foster scientific collaborations between EU and UK researchers in a post-Brexit era

Connects-UK, a new pan-European network dedicated to advancing scientific collaborations between researchers in the European Union (EU) and the United Kingdom (UK), was officially launched at an event in London yesterday. The network, led by a diaspora of EU researchers working in the UK, seeks to bridge the gap created by Brexit and ensure that collaboration, innovative research, funding, and knowledge exchange continue to thrive in the post-Brexit era.